Between 1997 and 2000, there was a decrease in hospitalisations, following the trend of the 1990s.
Similarly in one prospective single-centre study (n=47) HU was associated with a decrease in mean hospitalisation days from 29.3 days/year (95% CI 7 to 84) before HU to 3.2 days/year (95% CI 0 to 15) after HU, p<0.01.
We observed a marked decrease in hospitalisation time over calendar time among men with incidental prostate cancer.
Along with this, evidence from cohort studies and ecological evidence on recent smoking bans (introduced by law) consistently shows a rapid decrease in hospitalisation for myocardial infarction (MI).
In properly selected patients, CRT implantation is associated with improvement of symptoms and a decrease in mortality and hospitalisation for heart failure.
Moreover, after the introduction of new therapies, especially biological therapy, endoscopic mucosal healing has been proposed to be the treatment goal, because mucosal healing is associated with a decrease in rates of hospitalisation and surgery.
In an analysis based on nearly one million hospital admissions, we found a decrease in rates of hospitalisation for acute coronary events (ACEs) among both men and women aged under 70 in the two years following the introduction of a comprehensive smoking ban in Italy.
This is due to the large reduction in RVGE events, leading in turn to a substantial decrease in hospitalisations and consultations with office-based physicians, saving approximately €60 million and €6 million in direct medical costs, respectively, and approximately €64 million and €21 million, respectively, when indirect costs are also included (Table 4).
In 1989 Bone et al. [2] reported the benefits of early stabilisation of fractures in relation to a decrease in the duration of hospitalisation (early total care — ETC).
The decrease in healthcare costs with increasing persistence was attributed mainly to a decrease in the risk of hospitalisation.
